Evidence map›Paper›PMID 24877108›Full record

ArticleBioMed research international2014

New tools for embryo selection: comprehensive chromosome screening by array comparative genomic hybridization.

Lorena Rodrigo, Emilia Mateu, Amparo Mercader, Ana Cristina Cobo, Vanessa Peinado, Miguel Milán, Nasser Al-Asmar, Inmaculada Campos-Galindo, Sandra García-Herrero, Pere Mir and 2 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
11.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Preimplantation genetic testing in the current era, a review.Archives of gynecology and obstetrics · 2024
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Observational
  10. Article
  11. Article
  12. Preimplantation Genetic Testing: Where We Are Today.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. EnhancingGynecology and minimally invasive therapy
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Lorena RodrigoIVIOMICS SPAIN, Parc Cientific Universitat de València, Calle Catedrático Agustín Escardino 9, 46980 Valencia, Spain ; Instituto Valenciano de Infertilidad (IVI), Instituto Universitario IVI/INCLIVA, Plaza de la Policía Local 3, 46015 Valencia, Spain.ORCID 0000-0003-4133-9812
Emilia MateuIVIOMICS SPAIN, Parc Cientific Universitat de València, Calle Catedrático Agustín Escardino 9, 46980 Valencia, Spain ; Instituto Valenciano de Infertilidad (IVI), Instituto Universitario IVI/INCLIVA, Plaza de la Policía Local 3, 46015 Valencia, Spain.ORCID 0000-0003-0838-9981
Amparo MercaderInstituto Valenciano de Infertilidad (IVI), Instituto Universitario IVI/INCLIVA, Plaza de la Policía Local 3, 46015 Valencia, Spain.ORCID 0000-0002-5476-3703
Ana Cristina CoboInstituto Valenciano de Infertilidad (IVI), Instituto Universitario IVI/INCLIVA, Plaza de la Policía Local 3, 46015 Valencia, Spain.
Vanessa PeinadoIVIOMICS SPAIN, Parc Cientific Universitat de València, Calle Catedrático Agustín Escardino 9, 46980 Valencia, Spain.ORCID 0000-0003-3788-7728
Miguel MilánIVIOMICS SPAIN, Parc Cientific Universitat de València, Calle Catedrático Agustín Escardino 9, 46980 Valencia, Spain.
Nasser Al-AsmarIVIOMICS USA, 1200 NW 78th Avenue, Suite 103, Miami, FL 33126, USA.
Inmaculada Campos-GalindoIVIOMICS SPAIN, Parc Cientific Universitat de València, Calle Catedrático Agustín Escardino 9, 46980 Valencia, Spain.ORCID 0000-0003-3961-8628
Sandra García-HerreroIVIOMICS SPAIN, Parc Cientific Universitat de València, Calle Catedrático Agustín Escardino 9, 46980 Valencia, Spain.
Pere MirIVIOMICS INDIA, 13 Olof Palme Marg, Vasant Vihar, New Delhi 11057, India.
Carlos SimónIVIOMICS SPAIN, Parc Cientific Universitat de València, Calle Catedrático Agustín Escardino 9, 46980 Valencia, Spain ; Instituto Valenciano de Infertilidad (IVI), Instituto Universitario IVI/INCLIVA, Plaza de la Policía Local 3, 46015 Valencia, Spain ; Fundación IVI, 46980 Valencia, Spain ; Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA 94305, USA.
Carmen RubioIVIOMICS SPAIN, Parc Cientific Universitat de València, Calle Catedrático Agustín Escardino 9, 46980 Valencia, Spain ; Instituto Valenciano de Infertilidad (IVI), Instituto Universitario IVI/INCLIVA, Plaza de la Policía Local 3, 46015 Valencia, Spain.ORCID 0000-0002-7582-3875
Parc Científic de la Universitat de València · ESValencian Infertility Institute · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to evaluate the usefulness of comprehensive chromosome screening (CCS) using array comparative genomic hybridization (aCGH). The study included 1420 CCS cycles for recurrent miscarriage (n = 203); repetitive implantation failure (n = 188); severe male factor (n = 116); previous trisomic pregnancy (n = 33); and advanced maternal age (n = 880). CCS was performed in cycles with fresh oocytes and embryos (n = 774); mixed cycles with fresh and vitrified oocytes (n = 320); mixed cycles with fresh and vitrified day-2 embryos (n = 235); and mixed cycles with fresh and vitrified day-3 embryos (n = 91). Day-3 embryo biopsy was performed and analyzed by aCGH followed by day-5 embryo transfer. Consistent implantation (range: 40.5-54.2%) and pregnancy rates per transfer (range: 46.0-62.9%) were obtained for all the indications and independently of the origin of the oocytes or embryos. However, a lower delivery rate per cycle was achieved in women aged over 40 years (18.1%) due to the higher percentage of aneuploid embryos (85.3%) and lower number of cycles with at least one euploid embryo available per transfer (40.3%). We concluded that aneuploidy is one of the major factors which affect embryo implantation.

Indexed as

Abortion, HabitualAdultComparative Genomic HybridizationEmbryo, MammalianEmbryo TransferFemaleHumansMaleOligonucleotide Array Sequence AnalysisOocytesPregnancyTrisomy

Identifiers

PMID24877108
PMCPMC4022197
OpenAlexW1983529946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.